
NDP calls for investigation into Sudbury's Countryside Extendicare
However, the state of affairs indicates not all is well at Countryside Extendicare, Sudbury's newest long-term care home with 256 beds. It opened last year after Extendicare closed its facility on Falconbridge Road.
'The place looks absolutely beautiful from the outside, but what goes on, on the inside, is a totally different story,' Kim Blanchette said about Countryside.
Blanchette's father is at Countryside and she spoke to The Star shortly after problems began to surface.
A visit by assessors prompted the Ministry of Health and Long-Term Care to issue a cease admissions order on Dec. 16, 2024. As a result, Countryside cannot accept new patients until non-compliance issues are corrected.
Four months later, the order remains in effect.
Meanwhile, families and people connected to residents living at Countryside Extendicare continue to be concerned.
And Sudbury's two NDP MPPs - Jamie West (Sudbury) and France Gelinas (Nickel Belt) - said in a letter to Natalia Kusendova-Bashta, Ontario's minister of Long-Term Care, that they want the province to investigate Countryside.
They wrote that while Countryside management and the province have said many issues have been addressed, families are not convinced. The MPPs said they met the Extendicare Countryside Family Council on April 9.
'During that meeting, members of the council shared distressing concerns about the actual conditions in the home,' they wrote. 'Families describe the situation as nothing short of a crisis, and shared examples of residents feeling neglected, unsafe, and unheard.
'Furthermore, the families stated that these concerns have not been addressed, and they are frustrated that the compliance orders have been lifted despite no visible improvements.
'The contrast between what is being reported by Extendicare's senior management and the experiences being shared by those on the ground is stark. We respectfully request that your office investigate the growing discrepancies between the reports shared by senior management at Extendicare Countryside and the troubling accounts we are hearing from residents and their families.'
They said the families are concerned about a range of issues, including poorly trained staff, poor wound care and hygiene, and inconsistent feeding practices.
Worried about her father
Blanchette said she has noticed many of these issues with her father, including poor hygiene. She is concerned about fungal problems and the possible presence of Methicillin-resistant Staphylococcus aureus (MRSA) bacteria.
MRSA is resistant to many antibiotics so it can be difficult to treat.
'A lot of the residents I have talked to are so happy that all this information has come out publicly. I am very tired right now, as I just got home from Parry Sound, visiting with my husband's almost 96-year-old mother.
'She's in the Lakeland Long Term Care Facility, attached to the Parry Sound Hospital. She is being very well looked after there. Quite the contrast between both long-term care facilities. Just the quality of the meals is a significant contrast.'
Blanchette said she takes some comfort that problems at Countryside have become public and that it 'wasn't just me going through such stress … and feeling so helpless ...
'My dad now has an open wound on his private area, and was put on four different medications to help heal his severe diaper rash.'
Blanchette reported this problem to an RN on Oct. 28, 2024. She was called a 'couple days later to advise me that, after Dad was showered, they would be spraying a barrier cream on him … this is only the fourth infection he's had since entering the Countryside Extendicare since May 22, 2024. We have been dealing with a bed sore on his heel and two large toenail infections since June.
'No one told me about MRSA for three months, until his clothes piled up over his laundry hamper the Extendicare put in his room for quarantined laundry. A PSW came rushing at me, in the hallway, and said I couldn't put his clothing in the regular laundry and she grabbed it all out and put it back in his room.
'I asked why my Dad's laundry was quarantined and she had no idea. She said to go to the nurses' station and inquire there. The RN looked on the computer, and couldn't find anything about the quarantine order, so she told me to go to the Owl's Nest and speak to the RN there.
'This nurse, Jessica, I think, looked into it, and said 'Yes, they did a swab on Aug. 20, and it came back indicating MRSA.' This was now the middle of November and this is the first I heard that the infection had developed into MRSA.'
Concerns growing
Don Bourré also spoke to The Star after Countryside's problems became common knowledge. He attended a town hall last year at the facility to learn more.
'My girlfriend's mother is 97,' Bourré said. 'She was living in her own home up until recently' when she suffered a broken hip.
The elderly woman stayed at the Clarion Hotel for a time, where the St. Joseph's Continuing Care Centre was treating patients temporarily. She then moved into Countryside.
'Prior to the meeting, we were extremely happy with Countryside. We thought Countryside was the Taj Mahal,' Bourré said.
'But getting the notice and attending the (town hall) meeting, fear has been set in. It was not there before. Hearing the horror stories, we are starting to doubt. Is it possible that it is happening more than what is being reported? This was an eye-opener.
'What struck me the most – I am basing this on my own work experience – is that they need to tackle this right away, and get things back into shape. As the former VP of a large company, I looked after 165 stores and know how to fix things fast.
'These complaints that were brought forward by the (town hall) audience should have been resolved. Why are issues lingering? It baffles me. That they needed an outside group to come in and tell them things are bad … I don't understand. My mother-in-law had a fall … now we are forced to reassess how it happened and what was done.'
Laura Tamblyn-Watts, president and CEO of CanAge, is committed to better elder care and seniors' rights. She said the concerns expressed are not just a Countryside problem.
'At CanAge, we hear daily about the ongoing concerns of people in long-term care, the worries of their families and the mounting frustration that the levels of care and support needed for our most vulnerable are not being met,' Tamblyn-Watts said. 'Care staff will say the same. They are often stretched to the limit and have only minutes per resident to get people up, dressed, medicated, bathed and moving. It's not sustainable for anyone.
'New long-term care homes such as this one may have the benefit of more modern facilities, but (has) the risks of new staff and systems failing. It is clear that this home is in trouble and help needs to be given to the residents as well as staff support.
'In a home where people are completely reliant on others for their well-being, residents and families often fear complaining and being labelled a troublemaker. While this should never happen, of course, it happens regularly ...
'In the end, the core issue is that seniors' care isn't either funded or seen as high-priority work, with very high staff turnover and very low wages. Until we start fixing the whole of home and community care, helping family caregivers financially and recruiting and retaining well-trained staff with good jobs, the story will never change.
'The good news is that we know exactly how to change it. The bad news is that despite building new long-term care homes, we are not yet able to provide the kind of quality care our vulnerable seniors need.'
How complaints addressed
The Star contacted Countryside with a series of questions about how it responds to concerns. Below is a list of those questions and Countryside's answers:
Q. How does Extendicare respond to complaints?
A. We value the feedback of our residents and their families and encourage them to share concerns as they arise.
Going forward, our focus is on listening more closely, increasing opportunities for direct engagement with our residents and families, and ensuring we report more frequently on home initiatives, care programs and how we are addressing challenges.
Q. Is there a protocol or standard operating procedure?
A. Our process includes:
- Thorough investigations of all complaints brought to our attention.
- Providing a response within 10 days, unless an extension is requested by the home if more time is needed to investigate properly.
- Tracking the progress of complaints investigations.
- Regular reporting back to the Ministry and our Resident Council and Family Council on the status of items of concern.
Q. Is what we are seeing a result of the transfer from Falconbridge to Countryside sort of growing pains?
A. The recent transition of our residents and team members to a new home, along with welcoming 50 additional residents, created new challenges that we are actively addressing.
Like other healthcare providers in Northern Ontario, we also face challenges recruiting permanent team members due to the health human resources shortage, requiring the use of agency staff to meet and exceed provincial requirements.
Q. Will those who expressed concerns be assured prompt attention, assurances and corrections?
A. We are grateful for the open dialogue and support from our partners in the Ministry and will continue to work to strengthen trust with our residents and their loved ones. We will provide regular status updates and continue to seek feedback on our path forward.
The Local Journalism Initiative is made possible through funding from the federal government.
sud.editorial@sunmedia.ca
Bluesky: @sudburystar.bsky.social
X: @SudburyStar
Hashtags

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles


Medscape
a day ago
- Medscape
Ointment Cuts Severe Radiation Mucositis in Nasopharyngeal Cancer
TOPLINE: Bacterial decolonization with mupirocin nasal ointment significantly lowered rates of severe acute radiation oral mucositis in patients with nasopharyngeal carcinoma undergoing radiotherapy. The intervention also reduced oral pain and dysphagia, and improved quality of life (QOL) without increasing radiation dermatitis. METHODOLOGY: Acute radiation oral mucositis is a common, debilitating complication of radiotherapy in patients with nasopharyngeal carcinoma. Research showed that oral Staphylococcus aureus, a potential factor in oral mucositis, can increase after radiotherapy. Mupirocin, an inexpensive topical antibiotic, can help eliminate S aureus from nasal and oral sites but has not been tested in this setting. Researchers conducted a phase 3 trial of 176 patients with nasopharyngeal carcinoma (median age, 52 years) undergoing radiotherapy, who were randomly assigned to receive either a bacterial decolonization regimen with mupirocin nasal ointment (n = 88) or standard of care (n = 88). The decolonization regimen consisted of mupirocin nasal ointment applied twice daily for 5 days, starting 3 days before radiotherapy, followed by a 1-week break; this cycle was repeated throughout treatment. All patients received routine oral care with Kangfuxin Liquid mouth rinses and nasal saline irrigation. The primary endpoint was the occurrence of severe (grade ≥ 3) oral mucositis during radiotherapy. Secondary endpoints were QOL, pain, S aureus colonization in the oral and nasal cavities, and the incidence of grade ≥ 2 radiation dermatitis. TAKEAWAY: Severe oral mucositis occurred in 22.7% of the mupirocin group vs 47.7% of the standard care group (relative risk, 0.48; P < .001). Kaplan-Meier analysis also showed a significantly lower cumulative incidence of severe oral mucositis among patients receiving mupirocin (22.8% vs 48.3%). Bacterial decolonization and the mean oral radiation dose were independent risk factors for severe acute radiation oral mucositis, with decolonization reducing the risk (odds ratio [OR], 0.27) and a higher radiation dose increasing the risk (OR, 3.93). Age (OR, 1.61; P = .16) and S aureus presence (OR, 1.59; P = .19) were not independent risk factors. At week 4, patients in the mupirocin group reported less oral pain (median score, 25.0 vs 50.0) and dysphagia (8.3 vs 33.3), with improvements sustained through treatment completion. The rates of grade ≥ 2 radiation dermatitis did not differ between the groups. By the end of treatment, S aureus colonization was significantly lower in the bacterial decolonization group at both nasal (9.4% vs 22.9%) and oral (5.9% vs 20.5%) sites. IN PRACTICE: 'This phase 3 randomized clinical trial demonstrated that the mupirocin-based BD [bacterial decolonization] therapy effectively reduced AROM [acute radiation oral mucositis] severity and improves QOL in patients with NPC [nasopharyngeal carcinoma] undergoing radiotherapy,' the authors of the study wrote, adding that mupirocin is a 'safe, simple, and cost-effective strategy to reduce AROM severity.' SOURCE: This study, led by Zhaohui Liao, BSN, Jiangxi Cancer Hospital, The Second Affiliated Hospital of Nanchang Medical College in Nanchang, China, was published online in JAMA Oncology. LIMITATIONS: Study limitations were single-center design and lack of placebo control. Oral mucositis assessment by a single evaluator could introduce subjectivity. The S aureus culture method might lack sensitivity, potentially underestimating colonization rates. DISCLOSURES: The trial received funding support from the Science and Technology Research Project of Education Department of Jiangxi Province, the Open Fund for Scientific Research of NHC Key Laboratory of Personalized Diagnosis and Treatment of Nasopharyngeal Carcinoma, National Natural Science Foundation of China, and 'Five-level Progressive' talent cultivation project of Jiangxi Province Key R&D Program, and Jiangxi Cancer Hospital & Institute. The authors reported having no conflicts of interest. This article was created using several editorial tools, including AI, as part of the process. Human editors reviewed this content before publication.


UPI
5 days ago
- UPI
Trial shows promise for new bloodborne staph infection treatment
The National Institute of Allergy and Infectious Diseases said a new treatment for bloodborne staph infections showed promise in a clinical trial. File Photo by Tamas Soki/EPA A new way to battle bloodborne staph infections could help save lives while combating the rise of antibiotic-resistant bacteria, according to new clinical trial results. Two intravenous doses of the antibiotic dalbavancin delivered seven days apart worked just as well as daily IV doses of conventional antibiotics in quelling Staphylococcus aureus bloodstream infections, researchers reported Wednesday in the Journal of the American Medical Association. "Given the small number of antimicrobial drugs available to treat Staphylococcus aureus bloodstream infections and the bacteria's growing drug resistance, establishing dalbavancin as a beneficial therapy for these severe infections gives us a vital new alternative to treat them," Dr. John Beigel said in a news release. He's acting director of microbiology and infectious diseases at the National Institute of Allergy and Infectious Diseases. NIAID sponsored and funded the trial, which involved 200 hospitalized adults with complicated staph blood infections treated at 23 medical centers in the U.S. and Canada. The patients were randomly assigned to receive either two doses of dalbavancin or daily IV antibiotics, with overall treatment lasting four to eight weeks. In all, 100 received dalbavancin and the same number had standard antibiotics. Dalbavancin is a relatively recent antibiotic discovery, approved by the U.S. Food and Drug Administration in May 2014, according to The standard antibiotics used depended on the type of staph a person had. Cefazolin or penicillin were used for regular staph, while vancomycin or daptomycin were implemented against antibiotic-resistant staph, also known as MRSA. Results showed that dalbavancin worked about as well as standard therapy, providing doctors a new option for treating a severe staph infection. "Our findings give patients and health care providers the data to support an extra choice when deciding on treatment for complicated S. aureus bacteremia," lead researcher Dr. Nicholas Turner, an assistant professor at Duke University School of Medicine in Durham, N.C., said in a news release. What's more, the dalbavancin was easier to deliver. People receiving daily antibiotics needed an implanted catheter that remained in place for the full duration of their treatment -- something that can lead to complications like blood clots and additional infections. By comparison, people receiving dalbavancin only needed a short catheter inserted twice for about an hour each time, researchers said. As a result, side effects like blood clots occurred more often in the standard treatment group compared to the dalbavancin group, researchers found. Serious side effects were about as common with dalbavancin as with standard antibiotics -- 40 cases versus 34 cases, results show. However, severe events leading to treatment discontinuation occurred in 12% of the standard treatment patients compared to 3% of those treated with dalbavancin. Researchers next plan to compare the cost-effectiveness of the two approaches. More information The Cleveland Clinic has more about staph infections. Copyright © 2025 HealthDay. All rights reserved.


Time Business News
6 days ago
- Time Business News
Hygiene Tech Meets Healing Proteins
Hospital-acquired infections can be caused by the cross-infection from surface and skin of patient, equipment, and healthcare staff. Various types of products and services are available to control hospital-acquired infections such as sterilization, cleaning & disinfection products, protective barriers, and endoscope reprocessing products. Increase in awareness regarding personal hygiene after COVID-19 is a major factor to boost the Hospital Infection Prevention and Control growth. Growth factors, proteins or peptides found in nature, are important for the control of cell actions like growth, specialization, movement, and survival. They attach to certain receptors on cell surfaces, which starts signals inside the cells that change how they act. Growth factors are needed for body functions such as development in embryos, healing wounds, fixing tissues, and immune reactions. Key Growth Drivers and Opportunities High Cases of Hospital Acquired Infections: Hospital-acquired infections (HAIs) remain a major risk to patient safety and healthcare results around the world. These infections, often caused by bacteria like Staphylococcus aureus, Clostridium difficile, and Escherichia coli, usually happen because of long hospital stays, surgeries, poor infection control, and antibiotic resistance. Those in intensive care, people with weak immune systems, and those having surgery are at risk. HAIs raise sickness and death rates; these also cause higher medical costs and longer stays in hospitals. Growing Geriatric Population: The growing geriatric population significantly contributes to the rise in hospital-acquired infections, as older adults often have weakened immune systems and require frequent medical care or hospitalization. This increases their vulnerability to infections, driving the demand for effective hospital infection prevention and control measures. As a result, healthcare facilities are investing more in disinfection, protective equipment, and sterilization solutions to ensure patient safety and reduce infection risks in aging populations. Challenges Failure of end-users to follow infection prevention rules limits how well hospital infection control works. When staff, patients, or support people don't follow hygiene rules—such as washing hands, sterilizing tools, or using safety gear— the risk of contamination and infections rises. Innovation and Expansion NAVTA & Virox Launch Free Infection Control Training for Safer Vet Care In March 2023, (National Association of Veterinary Technicians in America) NAVTA, Virox launch certificate program in infection prevention, to advance best practices in infection prevention. This program is a free online program designed to provide professionals with the knowledge needed to reduce the risk of spreading infection and create a safer workplace for their team, patients, and clients. NeoIPC Unveils Toolkit to Shield Newborns from Hospital Infections In November 2023, The NeoIPC Consortium announced the launch of a new surveillance toolkit to help neonatal intensive care units (NICUs) track and prevent hospital-acquired infections (HAIs) in high-risk newborns, including very preterm infants. This toolkit aims to standardize how infections are tracked in Newborn Intensive Care Units (NICUs) to allow for improved data gathering and assessment. It has tools, training, and reporting forms made for newborn care locations. By helping with early detection and response, this project hopes to lower infection rates and improve results for fragile newborns. Inventive Sparks, Expanding Markets The key players operating the hospital infection prevention and control market includes, 3M Company, Crosstex International, Inc., Johnson & Johnson, Belimed AG, among others. Worldwide business aims center on encouraging lasting growth, improving health and safety for the public, and boosting progress through cooperation. About Author: Prophecy is a specialized market research, analytics, marketing and business strategy, and solutions company that offer strategic and tactical support to clients for making well-informed business decisions and to identify and achieve high value opportunities in the target business area. Also, we help our client to address business challenges and provide best possible solutions to overcome them and transform their business. TIME BUSINESS NEWS